• Pet wellness brand, Petervescence, has introduced treat-a-balls, a new line of premium dog treats made in New Zealand with human-grade, plant-based ingredients.
Source: Petervescence
    Pet wellness brand, Petervescence, has introduced treat-a-balls, a new line of premium dog treats made in New Zealand with human-grade, plant-based ingredients. Source: Petervescence
Close×

Pet wellness brand, Petervescence, has introduced treat-a-balls, a new line of premium dog treats made in New Zealand with human-grade, plant-based ingredients.

As pet ownership in Australia reaches one of the highest rates globally – 69 per cent of households – treat-a-balls meets the growing trend of pet parenting, by offering nutritious, health-focused treats for pets who are part of the family.

Available in three fruit-and-veggie-packed flavours – Cranberry, Pumpkin & Apple; Mango, Chia & Spinach; and Peanut Butter, Blueberry & Banana – treat-a-balls bring a new, innovative option to the market.

Each 18-ball pack (RRP $12.99 including GST) is non-GMO, gluten-free, and free from refined sugars, fillers, additives, and preservatives. These treats are formulated to provide a balanced, plant-based addition to a dog’s diet at any life stage.

Petervescence co-founder, Neil Cox, said the company created Treat-a-Balls with the belief that pet treats should meet the same quality standards as human food.

“With the global human-grade pet food market now valued at an estimated USD $129 billion, we wanted to bring the same level of quality to treats, using clean, plant-based ingredients that both pet owners and pets can enjoy,” said Cox.

Produced with FDA-approved, human-grade ingredients, treat-a-balls are held to the same standards as human food, with clean, transparent ingredients and no fillers or GMOs. The treats also come in recyclable packaging, underscoring Petervescence’s commitment to sustainable practices.

Packaging News

The merger between packaging giants Amcor and Berry is now complete, with the all-scrip deal creating a company with some 400 packaging plants, and 75,000 staff, located in 140 countries.

Pact Group is facing softening demand in Q4, citing Donald Trump’s tariffs, the ongoing domestic cost of living pressures, and supply chain disruption with shipping container supply tightening.

Raphael Geminder is following through on his stated intention to delist Pact Group in light of his failed takeover of the company, and has set 16 July as the date he wants it off the ASX.